• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】44889

【品名】 

【CA登记号】

【 分 子 式 】C20H28N4O5

【 分 子 量 】404.46628

【元素组成】C 59.39% H 6.98% N 13.85% O 19.78%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(XVII)

Reductive condensation of 2-oxopiperazine (I) with 4-oxopiperidine-1-carboxylic acid t-butyl ester (XIV) in the presence of sodium cyanoborohydride (NaBH3CN) in MeOH/EtOH-HCl yields derivative (XV), which is then coupled to bromo derivative (IV) by means of sodium in refluxing toluene to give compound (XVI). Deprotection of (XVI) by treatment with TFA and anisole provides piperidine derivative (XVII), which is then treated with chloromethyl chloroformate (X) and proton sponge in CH2Cl2 to furnish derivative (XVIII). Finally, (XVIII) is coupled to pivalic acid (XII) by means of K2CO3 in DMF and converted into the corresponding hydrochloride salt by treatment with HCl-EtOH in EtOAc.

1 Katano, K.; Ohuchi, S.; Miura, T.; Shitara, E.; Shimizu, M.; Yaegashi, K.; Ohkura, N.; Isomura, Y.; Iida, H.; Ishikawa, M.; Asai, K.; Hatsushiba, E. (Meiji Seika Kaisha, Ltd.); Novel cpd. having platelet aggregation inhibitor effect. EP 0721941; US 5814636; WO 9602503 .
2 Ohuchi, S.; Suzuki, H.; Ando, T.; Katano, K.; Imai, T.; Kobayashi, K.; Ota, K.; Aizawa, K.; Miura, T. (Meiji Seika Kaisha, Ltd.); Nitrogen-containing heterocyclic cpds. having antiplatelet aggregation effect and medicinal use thereof. EP 1070712; WO 9952894 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 44876 2-piperazinone C4H8N2O 详情 详情
(IV) 44878 ethyl 2-[4-(1lambda(3)-dibromanylcarbonyl)phenoxy]acetate C11H12Br2O4 详情 详情
(X) 19249 Chloromethyl chloroformate; Chloro[(chlorocarbonyl)oxy]methane 22128-62-7 C2H2Cl2O2 详情 详情
(XII) 44281 pivalic acid 75-98-9 C5H10O2 详情 详情
(XIV) 44886 tert-butyl 4-oxo-4lambda(5)-piperazine-1-carboxylate C9H18N2O3 详情 详情
(XV) 44887   C13H24N4O3 详情 详情
(XVI) 44888   C24H35BrN4O7 详情 详情
(XVII) 44889   C20H28N4O5 详情 详情
(XVIII) 44890   C22H29ClN4O7 详情 详情
Extended Information